FundedIQ
Biotechnology

Archon Biosciences: Funding, Investors & Team (Nov 2026)

Archon is a biotechnology company developing computationally designed proteins to unlock powerful therapeutic targets that lie beyond the reach of existing modalities and to better treat disease. We directly apply generative protein design to create a new biologic class, Antibody Cages (AbCs), that integrates the industry-proven affinity and specifiUK antibodies into self-assembling nanostructures. Precise control over AbC structure provides the ability to tune both how they distribute in the body and engage their cellular targets with high specificity and potency to establish a new gold-standard for biologic medicines. Archon Biosciences is based in Seattle and supported by a team of forward-thinking investors led by Madrona Ventures. Our AbC platform was invented with the science and technology recognized by the 2024 Nobel Prize in Chemistry at the Baker Lab in the Institute for Protein Design (IPD).

www.archon.bio LinkedIn Washington, United States 11-50 employees
Biotechnology Therapeutics
Total raised
$20.0M
Rounds
1
Latest
Seed
Oct 2024

Archon Biosciences has raised $20.0M across 1 funding round on record, the most recent a Seed of $20.0M announced in Oct 2024.

That round is above the $8.9M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Archon Biosciences Company Profile and Key Stats

Total funding raised
$20.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$20.0M in Oct 2024
Employees
11-50
reported band
Headquarters
Washington, United States

Latest funding round on record: Oct 2024.

Archon Biosciences Funding Rounds

Date
Round
Amount
Seed
$20.0M

Archon Biosciences Founders and Leadership Team

Name
Role
Contact
James Lazarovits
Founder
Locked

Contact details for the Archon Biosciences team: 1 of 1 has an email address on file.

Start 14-day free trial →

Archon Biosciences Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,188
$8.9M
30,615
$7.8M
17,445
$3.1M

Archon Biosciences' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Archon Biosciences in Biotechnology and Washington

Companies Similar to Archon Biosciences

Araceli Biosciences specializes in creating scientific instruments for discovering tissue- and cell-based…

Seed $4.5M

Switchpoint Bio is a biotechnology company that offers immune relevant drug treatments.

Pre-Seed $5.3M

Nanopath Inc. is a company that specializes in molecular diagnostics and allows for fast, high-quality…

Series B $25.0M

Frontier Bio is creating lab-grown human tissues as an ethical replacement for animal studies and is setting…

Undisclosed round $380k

Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel…

Series C $100M

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus…

Series B $41.9M

Zafrens, a pharmaceutical research organization, focuses on designing life sciences solutions for…

Series A $6.0M

Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes.…

Series D —

Arctic Therapeutics specializes in finding the genetic origins of common diseases and creating successful…

Undisclosed round $21.5M

100XBIO is creating a cutting-edge platform for analyzing multiple T-cells automatically, aiming to…

Pre-Seed $110k

MEND is a company focused on life sciences, determined to assist individuals in achieving better health…

Undisclosed round $1.5M

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Archon Biosciences Funding FAQs

What does Archon Biosciences do?

Archon is a biotechnology company developing computationally designed proteins to unlock powerful therapeutic targets that lie beyond the reach of existing modalities and to better treat disease. We directly apply generative protein design to create a new biologic class, Antibody Cages (AbCs), that integrates the industry-proven affinity and specifiUK antibodies into self-assembling nanostructures. Precise control over AbC structure provides the ability to tune both how they distribute in the body and engage their cellular targets with high specificity and potency to establish a new gold-standard for biologic medicines. Archon Biosciences is based in Seattle and supported by a team of forward-thinking investors led by Madrona Ventures. Our AbC platform was invented with the science and technology recognized by the 2024 Nobel Prize in Chemistry at the Baker Lab in the Institute for Protein Design (IPD).

How much funding has Archon Biosciences raised?

Archon Biosciences has raised $20.0M across 1 round on record. The most recent is a Seed of $20.0M announced in Oct 2024.

When did Archon Biosciences last raise funding?

Archon Biosciences' most recent funding round on record is a Seed of $20.0M, announced in Oct 2024.

Who founded Archon Biosciences?

FundedIQ lists James Lazarovits (Founder) at Archon Biosciences.

Where is Archon Biosciences headquartered?

Archon Biosciences is based in Washington, District of Columbia, United States.

How many employees does Archon Biosciences have?

Archon Biosciences is in the 11-50 employee band.

How does Archon Biosciences' funding compare to other Biotechnology startups?

Archon Biosciences' latest round of $20.0M is above the $8.9M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.

About FundedIQ's Archon Biosciences Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Archon Biosciences is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.